Publications by authors named "M Noureldin"

Proteolysis-targeting chimeras (PROTACs) have been explored for the degradation of drug targets for more than two decades. However, only a handful of E3 ligase substrate receptors have been efficiently used. Downregulation and mutation of these receptors would reduce the effectiveness of such PROTACs.

View Article and Find Full Text PDF

Aberrant activation of the NLRP3 inflammasome is recognized to induce a chronic inflammatory response in the liver, ultimately leading to hepatic fibrosis. HSP90 is suggested to regulate NLRP3 activation and its downstream signaling. This study is the first to explore the potential therapeutic role of pimitespib in mitigating liver fibrosis in rats.

View Article and Find Full Text PDF

This study utilizes artificial neural networks (ANN) to estimate prediction intervals (PI) for seismic performance assessment of buildings subjected to long-term ground motion. To address the uncertainty quantification in structural health monitoring (SHM), the quality-driven lower upper bound estimation (QD-LUBE) has been opted for global probabilistic assessment of damage at local and global levels, unlike traditional methods. A distribution-free machine learning model has been adopted for enhanced reliability in quantifying uncertainty and ensuring robustness in post-earthquake probabilistic assessments and early warning systems.

View Article and Find Full Text PDF

Background: The Pharmacists' Patient Care Process (PPCP) is a 5-step approach for patient-centered evidence-based pharmaceutical care. The PPCP was developed by the Joint Commission of Pharmacy Practitioners in 2014; however, little is known about PPCP terminology and process uptake across the profession.

Objectives: This study aimed to explore practicing pharmacists' awareness of and confidence in performing PPCP-related activities in various practice settings.

View Article and Find Full Text PDF
Article Synopsis
  • Cannabis may offer a pain management alternative for patients with inflammatory bowel disease (IBD) as opposed to using opioids.
  • A study analyzed opioid prescribing trends in states with legalized cannabis versus those without, focusing on a sample of IBD patients.
  • Results showed that opioid prescribing rates decreased over time in both groups, indicating cannabis legalization did not significantly impact opioid use among IBD patients.
View Article and Find Full Text PDF